GoodRx a Aktie
WKN DE: A2QBX9 / ISIN: US38246G1085
|
07.11.2024 12:43:58
|
GoodRx Q3 Profit Misses View
(RTTNews) - GoodRx Holdings, Inc. (GDRX), a digital healthcare platform, Thursday reported net income of $3.97 million or $0.01 per share for the third quarter compared with net loss of $38.49 million or $0.09 per share in the same quarter a year ago, helped by increase in revenue as well as decline in costs and expenses.
Excluding one-time items, earnings were $31.94 million or $0.08 per share, that missed the analysts' average estimate of $0.09 per share. Analysts' estimates typically exclude special items.
Revenue for the quarter grew 8 percent to $195.25 million from $179.96 million in the previous year. Adjusted Revenue increased 3 percent to $195.3 million from $190 million. The consensus estimate was for $195.65 million.
For the fourth quarter, the company sees revenue of nearly $200 million. The Street is looking for revenue of $206.25 million for the quarter.
For the full year, GoodRx expects revenue to be about $794 million. This compares with analysts' average estimate of $800.8 million.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu GoodRx Holdings Inc Registered Shs -A-mehr Nachrichten
|
20.10.25 |
Erste Schätzungen: GoodRx A präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
|
19.08.25 |
Novo Nordisk-Aktie gewinnt: Ozempic-Preissenkung und GoodRx-Kooperation überzeugen Anleger (finanzen.at) | |
|
05.08.25 |
Ausblick: GoodRx A legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
|
23.07.25 |
Erste Schätzungen: GoodRx A legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) |
Analysen zu GoodRx Holdings Inc Registered Shs -A-mehr Analysen
Aktien in diesem Artikel
| GoodRx Holdings Inc Registered Shs -A- | 3,95 | 2,33% |
|